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Abstract
Background: Higher serum concentrations of 25-hydroxyvitamin D (25(OH)D), an indicator of vitamin D synthesis and
intake, have been associated with better mental health and cognitive function. Concentrations of 1,25-dihydroxyvitamin D3
(the active vitamin D3 metabolite) have been associated with openness and extrovert behaviour, but 25(OH)D
concentrations have not been associated with behavioural problems in humans.
Methods: We investigated the prospective association between the different forms of 25(OH)D - 25(OH)D3 and 25(OH)D2–
and childhood behavioural problems in Avon Longitudinal Study of Parents and Children (ALSPAC). Serum 25(OH)D3 and
25(OH)D2 concentrations were assessed at mean age 9.9 years. Incident behavioural problems were assessed with Strengths
and Difficulties Questionnaire (SDQ; emotional symptoms, conduct problems, hyperactivity-inattention problems, peer
relationship problems and pro-social behaviour subscales and total difficulties score) at mean age 11.7. Sample sizes varied
between 2413-2666 depending on the outcome.
Results: Higher 25(OH)D3 concentrations were weakly associated with lower risk of prosocial problems (fully adjusted odds
ratio: OR (95% confidence interval: CI) 0.85 (0.74, 0.98)). Serum 25(OH)D3 or 25(OH)D2 concentrations were not associated
with other subscales of SDQ or total difficulties score after adjusting for concfounders and other measured analytes related
to vitamin D.
Conclusions: Our findings do not support the hypothesis that 25-hydroxyvitamin D status in childhood has important
influences on behavioural traits in humans.
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Introduction
Higher serum concentrations of 25-hydroxyvitamin D
(25(OH)D), an indicator of dietary intake and cutaneous synthesis
of vitamin D [1], have been associated with healthier cognitive and
mental health phenotypes, including better cognitive function [2–
7], and reduced risk of schizophrenia [8,9] and depression [10–
12], albeit with some inconsistencies between studies [13–15].
Animal experiments have shown associations between vitamin D
deficiency and aberrant behaviour, social functioning and lower
habituation (reviewed in [16–18]). A small study (n = 206) found
that higher serum 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)
concentrations were associated with more extrovert and open
behaviour in adults [19], while maternal serum 25(OH)D
concentrations during second [20] or third [21] trimester were
not associated with behavioural problems in children.
Circulatory 25(OH)D consists of 25(OH)D3 (synthesised from
vitamin D3 obtained mainly from skin synthesis and to a lesser
extent from animal food sources) and 25(OH)D2 (synthesised
from vitamin D2 obtained from certain plant food sources).
25(OH)D3 and 25(OH)D2 are converted to 1,25-dihydroxyvita-
min D3 and D2, the steroid hormones that mediate the
biological actions of vitamin D. The former has higher affinity
to vitamin D binding protein [22,23] and with respect to bone
health, vitamin D3 has been suggested to be more potent than
D2 [24]. The aims of this study were to investigate the
association of serum 25(OH)D3 and 25(OH)D2 concentrations
with behavioural problems in childhood and to compare
whether the associations of 25(OH)D3 and 25(OH)D2 are
different from each other. Because vitamin D, together with
parathyroid hormone (PTH), regulates calcium and phosphate
homoeostasis 23;24 we investigated whether the associations of
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The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a population-based birth cohort from South West
England. The cohort consisted of 14062 live births from 14541
pregnant women who were expected to give birth between April 1,
1991, and December 31, 1992 [25]. From age 7, all children were
invited for an annual assessment of physical and psychological
development. Parents gave written informed consent at enrolment,
and ethical approval was obtained from the ALSPAC Law and
Ethics Research Committee and the National Health Service
(NHS) local research ethics committee.
Single and twin births were included in this study; the very small
number of triplets and quadruplets were not included for reasons
of confidentiality. Figure 1 shows how the number included in the
analyses was derived. Depending on outcome, 2413–2666 children
had complete data on outcome, exposures and confounders.
Exposures and Blood Based Covariables
Serum 25(OH)D3, 25(OH)D2, PTH, phosphate and calcium
concentrations were assayed on non-fasting blood samples
collected at mean age 9.9 years for the majority of participants.
If no samples were available from the 9.9 years assessment,
samples from mean age 7.6 years or, secondly, the 11.8 years
assessment. The mean age at sample collection in the whole study
sample was 9.9 years (standard deviation: SD 1.05). Following
collection, samples were immediately spun, frozen and stored at –
80uc. 25(OH)D3 and 25(OH)D2 assays were performed with high
pressure liquid chromatography tandem mass spectrometer
(Waters Acuity, Manchester, UK) after a maximum of 12 years
in storage with no previous freeze-thaw cycles as described
previously [26]. Inter-assay coefficients of variation for the assay
were ,10% across a working range of 2.5–624 nmol/L for both
25(OH)D3 and 25(OH)D2. Measurements were performed in a
laboratory meeting the performance target set by the Vitamin D
External Quality Assessment Scheme (DEQAS) Advisory Panel for
25(OH)D assays.
Total serum calcium, phosphate and albumin concentrations
were measured by standard laboratory methods on Roche
Modular analysers (Roche Diagnostics Ltd, West Sussex, UK).
Serum calcium was adjusted for albumin using a normogram of
calcium and albumin distributions of the samples analysed in the
clinical chemistry laboratory where the measurements were
performed and albumin-adjusted calcium was used in all statistical
analyses. Intact parathyroid hormone (iPTH(1-84)) was measured
by electrochemiluminescent immunoassay on Elecsys 2010 im-
munoanalyzer (Roche, Lewes, UK). Inter-assay coefficient of
variation was ,6% from 2–50 pmol/L. The assay sensitivity was
1 pmol/L.
Outcomes
Behavioural problems were assessed using the Strengths and
Difficulties Questionnaire (SDQ), completed by parents when the
children were at mean ages 7.6, 9.6 and 11.7 years. The SDQ is a
behavioural screening questionnaire that has been validated for
use in children aged 4–16 years [27]. It includes 25 items relating
to positive and negative behaviours and these are used to score
children on five subscales: emotional symptoms, conduct prob-
lems, hyperactivity-inattention problems, peer relationship prob-
lems and pro-social behaviour. Scores on each scale range from
zero to ten and higher scores denote more problems, except on the
reverse-scored pro-social subscale in which higher scores indicate
more social behaviour. A total difficulties score (range 0–40) is
obtained by summing the scores for the emotional symptoms,
conduct problems, hyperactivity-inattention problems and peer
relationship problems scales. Only children whose parents
answered all questions in each subscale were included in this study.
Total difficulties score and scores from five subscales were
dichotomised according to cut-off values for borderline/abnormal
behaviour according to parent-rated SDQ (.13 for total
difficulties, .3 for emotional symptoms, .5 for hyperactivity-
inattention problems, .2 for conduct and peer problems and ,6
for prosocial behaviour). Full description of questionnaire and
information on cut-offs and normative values are available at
http://www.sdqinfo.org. In order to assess prospective associa-
tions of exposures with incident behavioural problems at age 11.7
years and to ensure that no associations were due to reverse
causality, we excluded any children with behavioural problems at
the age 7.6 or 9.6 assessments.
Confounders
We considered ethnicity (white, non-white), head of household
occupational social class, maternal and paternal education, family
history of depression or schizophrenia, exposure to ultraviolet B
(UVB), body mass index (BMI) and cognitive function to be
important confounders because of their known associations with
25(OH)D3 concentrations and behavioural problems. We also
adjusted for pubertal stage as this might affect behavioural
problems and 25(OH)D3.
Data on head of household social class, ethnicity, maternal and
paternal education and family history of depression and schizo-
phrenia were obtained from parent-completed questionnaires.
Time spent outdoors during summer months on school days,
school weekends and holidays was reported as ‘None’, ‘1 hour/
day’, ‘1–2 hours/day’ and ‘3 or more hours/day’ in parent-
completed questionnaires at mean age of 8.5 years. Responses
were coded as follows: ‘None` = 0, ‘1’ = 1, ‘1–2’ = 1.5 and ‘3’ = 5.
Average hours spent outdoors per summer day (June 1-August 31)
were calculated using term dates from Bristol City Council’s
Education Committee term dates for 2001-2002 (summer term
June 1-July 23, holidays July 24-August 31). Information on
protection from UVB exposure (use of sunblock, covering clothing
or hat and avoidance of midday sun) were obtained from the same
questionnaires. A summary variable for UVB protection score was
derived by scoring the responses to questions on use of sunblock,
covering clothing or hat and avoidance of midday sun as
‘Always’ = 3, ‘Usually’ = 2 ‘Sometimes’ = 1 ‘Never’ = 0 and sum-
ming these scores. This gives a single variable that ranges from
zero to twelve, with zero indicating the least meticulous protection
from UVB.
Height and weight were measured at the same time as blood
samples for obtaining 25(OH)D3 and other assays and were used
to calculate body mass index (BMI). Total IQ score in Wechsler
Intelligence Scale for Children (WISC-III UK version) was
assessed at mean age 8.5. Puberty stage was assessed by parental
report using Tanner staging [28] of breast, genitalia development
and pubic hair on repeat occasions. In our analyses we used data
from the questionnaire closest to the time of phlebotomy for the
exposures for each child.
Statistics
Statistical analyses were conducted with Stata 11.0 (Stata Corp
LP, College Station, TX USA). To adjust for seasonal variability
in 25(OH)D3, the latter was modeled according to date of blood
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sampling using linear regression with trigonometric sine and
cosine functions. 25(OH)D3 was loge transformed to reduce
heteroscedasticity. The residual was then used as 25(OH)D3
exposure variable in regression analyses of the main results. In
supplementary analyses we also report associations unadjusted (for
season) 25(OH)D3 and of total 25(OH)D [25(OH)D3 plus
25(OH)D2]. To include all participants on whom a 25(OH)D2
was assayed, those with a value below the detectable limit of the
assay (1.25 nmol/L, N= 1242-1622 depending on outcome) were
indicated using a binary covariable in all regression models. In
order to take account of age differences at the time of assessment
we generated age and gender standard deviation scores for serum
25(OH)D3, 25(OH)D2, calcium, phosphate and PTH using the
internal cohort data with age in 1 month categories.
The association of potential confounders with exposures was
assessed with linear regression and associations of confounders
Figure 1. Flow of participants.
doi:10.1371/journal.pone.0040097.g001
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with SDQ scales problems with logistic regression. Other analyses
were performed using a non-parametric bootstrap procedure in
conjunction with logistic regression, based on 1000 replications.
The bootstrapping procedure enabled us to statistically compare
associations of 25(OH)D3 with behavioural problems to those of
25(OH)D2 with behavioural problems. The difference between the
association of 25(OH)D3 and 25(OH)D2 was calculated from the
bootstrap replicate distribution. Beta estimates and standard errors
were empirically calculated from the mean and standard deviation
of the bootstrap distribution respectively. All P-values were
calculated using bootstrap means and standard errors and
compared to a z-distribution, 95% percentile confidence intervals
were calculated. In order to numerically compare the associations
of two forms of 25(OH)D, we scaled them the same by multiplying
the beta coefficients from the regression models by loge(2).
Analyses were performed for both genders combined as there
was no statistical evidence of gender*exposure interaction (all
P$0.20).
Because some children had exposure and outcome measured at
the same time (14.3–15.0%, n= 350–399 depending on outcome),
a separate analyses restricted to those with prospective exposure
measurement (age 7.6 or 9.9 years) was done to see if the exclusion
of more cross-sectional data affected the association. We also
assessed the association between the exposures and SDQ scores
with Poisson regression. These results are shown as supplementary
material.
Results
The median (interquartile range) serum season-adjusted
25(OH)D3, 25(OH)D2 and total 25(OH)D concentration were
59.8 (59.3–60.3), 3.3 (1.3–6.8) and 61.9 (49.9–74.9) nmol/L,
respectively. The median (interquartile range) for serum PTH,
phosphate and albumin-adjusted calcium were 4.5 (3.4–5.8) pmol/
L, 1.53 (1.43–1.64) mmol/L and 2.37 (2.31–2.44) mmol/L,
respectively.
Table 1 shows the distributions of SDQ scores in those children
who were excluded from this study due to missing data and in
those included. There were no differences in scores on any
subscales, but complete cases had slightly lower total difficulty
scores. Number (%) of children with borderline or abnormal
behaviour were 86 (3.5%) for total difficulties, 171 (6.7%) for
emotional symptoms, 255 (9.0%) for conduct problems 127 (4.9%)
for hyperactivity 197 (8.1%) for peer problems and 101 (3.8%) for
pro-social problems.
Table S1 shows the univariable associations of the potential
confounders with the exposures. Higher BMI was associated with
lower concentrations of 25(OH)D3 and 25(OH)D2 and higher
concentrations of PTH. Non-white ethnicity was associated with
higher PTH concentrations and children with higher IQ had
lower albumin-adjusted calcium concentrations. Children from
higher socioeconomic background had higher 25(OH)D3 concen-
trations and lower 25(OH)D2 and albumin-adjusted calcium
concentrations. Children who spent more time outdoors during
summer had higher 25(OH)D3 and 25(OH)D2 concentrations and
those with higher UVB protection score had lower PTH
concentrations. Family history of mental health problems was
associated with lower 25(OH)D3 and albumin-adjusted calcium
concentrations and higher PTH concentrations. Children with
more advanced puberty stage had higher phosphate and albumin-
adjusted calcium concentrations and lower 25(OH)D3 concentra-
tions.
Table 2 shows the univariable associations of confounders with
prosocial problems and total difficulties at mean age 11.7 years.
Higher BMI, lower IQ, lower socioeconomic position and more
advanced puberty stage were associated with higher risk of
behavioural problems. Children who had higher UVB protection
score were less likely to have prosocial problems. Univariable
associations with separate subscales of total difficulties were similar
(Table S2).
Table 3 shows the association of serum 25(OH)D3 and
25(OH)D2 concentrations with behavioural problems at mean
age 11.7 years. Serum 25(OH)D3 concentrations were not
associated with total difficulties, but when different subscales were
studies, higher serum 25(OH)D3 concentrations were associated
with lower risk of prosocial problems in the models adjusted for
and potential confounders (Model 2) and serum concentrations of
25(OH)D2, phosphate, calcium and PTH (Model 3). Serum
25(OH)D2 concentrations were not associated with total difficul-
ties. Higher serum 25(OH)D2 concentrations were weakly
associated with higher risk of prosocial problems in the confound-
er-adjusted model (Model 2), but no longer after adjusting for
other analytes. The associations of 25(OH)D3 and 25(OH)D2 with
social problems were different (P = 0.005), but there was no strong
statistical evidence that any of the associations of 25(OH)D3 with
outcomes differed from those of 25(OH)D2 with the same
outcomes (all other P for different effect $0.29). When partic-
ipants who had 25(OH)D3 and 25(OH)D2 assessed on a blood
sample that was taken at the same time as the outcome assessment
(mean age 11.7) were excluded, the results were essentially the
same as those including these participants (Table 4).
Table S3 shows the association of serum albumin-adjusted
calcium, phosphate and PTH concentrations with behavioural
problems at mean age 11.7. Serum PTH concentrations were
associated with higher risk of prosocial problems in the confound-
er-adjusted model (Model 2), but adjustment for other analytes
attenuated this association towards the null. Phosphate or
albumin-adjusted calcium concentrations were not associated with
behavioural problems.
Table S4 shows the associations of unadjusted (for season)
25(OH)D3 and Table S5 shows the associations of unadjusted (for
season) total 25(OH)D with behavioural problems at mean age
11.7 years. The associations were closer to the null value but
otherwise similar to those shown in Table 3.
Table S6 shows the associations of season-adjusted25(OH)D3
and 25(OH)D2 with continuous SDQ scores at mean age 11.7
years. Neither 25(OH)D3 nor 25(OH)D2 were associated with total
difficulties score or scores in any SDQ subscale.
Discussion
Despite suggestive findings from animal studies, that vitamin D
deficiency might be related to behavioural problems (reviewed in
[16–18]), we found no strong or robust associations between serum
25(OH)D3 and 25(OH)D2 concentrations and behavioural prob-
lems in children. Only a weak association between lower
25(OH)D3 and higher 25(OH)D2 concentrations and higher risk
of prosocial problems was observed. One previous small study
(n= 206) in adults found that higher 1,25(OH)2D3 concentrations
were associated with fewer behaviour problems [19], but as
1,25(OH)2D3 is the active hormone metabolite of vitamin D and
its serum concentrations do not necessarily reflect vitamin D
synthesis and intake [29,30], which are more accurately reflected
by serum 25(OH)D concentrations [1,29], it is difficult to compare
our results to those of the previous study [19]. Our findings are
consistent with two previous studies that assessed the association
between maternal 25(OH)D concentrations during pregnancy and
behavioural problems in childhood and concluded with null results
Vitamin D and Behavioural Problems
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Table 1. Distribution of Strengths and Difficulties scores in children who were excluded due to missing data and in those included
in at least one of the association analyses.
Outcome Median (interquartile range), minimum, maximum, N
Excluded due to missing data Included in at least one analysis
Total difficulties 5 (3, 9), min = 0 max = 34, N = 3636 5 (3, 8), min = 0 max = 27, N = 2561
Emotional symptoms 1 (0, 2), min = 0 max = 10, N = 4188 1 (0, 2), min = 0 max = 10, N = 2580
Conduct problems 1 (0, 2), min = 0 max = 10, N = 4151 1 (0, 2), min = 0 max = 9, N = 2841
Hyperactivity 2 (1, 4), min = 0 max = 10, N = 4144 2 (1, 4), min = 0 max = 10, N = 2838
Peer problems 0 (0, 2), min = 0 max = 9, N = 4008 0 (0, 2), min = 0 max = 9, N = 2755
Prosocial behaviour 9 (7, 10), min = 0 max = 10, N = 4184 9 (7, 10), min = 0 max = 10, N = 2840
doi:10.1371/journal.pone.0040097.t001
Table 2. Univariable associations between potential confounders and prosocial problems and total difficulties.
Prosocial problems Total difficulties
Odds ratio per SD/category change
(95%CI) P
Odds ratio per SD/category change
(95%CI) P
BMI (kg/m2) 1.02 (0.98, 1.07) 0.27 1.02 (0.97, 1.07) 0.53
WISC full IQ score at 8.5 yearsa 0.95 (0.84, 1.07) 0.41 0.65 (0.57, 0.74) ,0.001
Non-white ethnicity 0.95 (0.84, 1.07) 0.12 1.14 (0.61, 2.12) 0.68
Head of household social class
i 1 (reference) 0.87 1 (reference) ,0.001
ii 1.04 (0.73, 1.48) 1.15 (0.78, 1.72)
iii non-manual 1.02 (0.69, 1.50) 1.56 (1.02, 2.36)
iii manual 0.91 (0.55, 1.51) 1.39 (0.83, 2.35)
iv/v 1.09 (0.56, 2.09) 2.83 (1.56, 5.13)
Paternal education
None/CSE 1 (reference) 0.10 1 (reference) 0.033
Vocational 0.99 (0.62, 1.58) 0.97 (0.59, 1.60)
O level 0.91 (0.64, 1.30) 0.77 (0.52, 1.13)
A level 0.72 (0.51, 1.02) 0.87 (0.61, 1.24)
Degree 2.00 (1.13, 3.55) 0.62 (0.42, 0.92)
Maternal education
None/CSE 1 (reference) 0.025 1 (reference) ,0.001
Vocational 1.20 (0.76, 1.90) 0.81 (0.49, 1.31)
O level 0.80 (0.56, 1.15) 0.59 (0.41, 0.85)
A level 0.70 (0.47, 1.03) 0.54 (0.37, 0.80)
Degree 0.75 (0.49, 1.15) 0.42 (0.27, 0.66)
UVB protection score 0.90 (0.85, 0.95) ,0.001 0.97 (0.92, 1.03) 0.33
Average h/day spent outdoors during summer 1.05 (0.93, 1.18) 0.46 1.05 (0.93, 1.20) 0.43
Family history of depression/schizophrenia
None 1 (reference) 0.77 1 (reference) ,0.001
Depression 1.10 (0.83, 1.46) 2.10 (1.58, 2.79)
Schizophrenia 0.59 (0.14, 2.42) 1.91 (0.68, 5.35)
Puberty stage at serum measurement
1 1 (reference) 0.003 1 (reference) 0.008
2 1.50 (1.07, 2.10) 1.15 (0.79, 1.67)
3 1.61 (1.10, 2.35) 1.72 (1.16, 2.56)
4–5 1.87 (1.09, 3.19) 1.62 (0.89, 2.93)
aIQ score was divided by 15 in order to produce odds ratios for a 15-point increase in IQ.
doi:10.1371/journal.pone.0040097.t002
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Table 3. Association of 25(OH)D3 and 25(OH)D2 concentrations with incident behavioural problems assessed by Strengths and
Difficulties Questionnaire at mean age 11.7 years in children with exposures assessed at 7-,9- or 11-year clinic (mean age 9.8 years,
N = 2413–2666a).
Exposure Outcomea
Odds ratio for category change per
doubling of exposure (95%CI)
Model 1 Model 2 Model 3
25(OH)D3 Total difficulties 0.89 (0.77, 1.02) 0.88 (0.76, 1.02) 0.88 (0.75, 1.02)
Emotional symptoms 0.96 (0.86, 1.06) 0.97 (0.87, 1.06) 0.97 (0.86, 1.08)
Conduct problems 0.92 (0.82, 1.02) 0.92 (0.82, 1.03) 0.92 (0.82, 1.03)
Hyperactivity 1.06 (0.94, 1.20) 1.05 (0.93, 1.17) 1.04 (0.91, 1.17)
Peer relationship problems 0.94 (0.84, 1.04) 0.96 (0.87, 1.06) 0.95 (0.85, 1.05)
Pro-social problems 0.84 (0.73, 0.96) 0.84 (0.72, 0.98) 0.85 (0.74, 0.98)
25(OH)D2 Total difficulties 0.88 (0.71, 1.09) 0.87 (0.69, 1.10) 0.85 (0.66, 1.06)
Emotional symptoms 1.00 (0.84, 1.19) 0.99 (0.83, 1.21) 0.99 (0.81, 1.20)
Conduct problems 1.02 (0.88, 1.18) 1.02 (0.88, 1.18) 1.02 (0.87, 1.20)
Hyperactivity 1.06 (0.87, 1.28) 1.03 (0.83, 1.26) 1.03 (0.84, 1.25)
Peer relationship problems 1.05 (0.90, 1.22) 1.05 (0.90, 1.22) 1.06 (0.90, 1.25)
Pro-social problems 1.26 (0.97, 1.61) 1.30 (1.01, 1.68) 1.26 (0.97, 1.61)
Model 1 is unadjusted (the exposures are standardised for age and gender and 25(OH)D3 is adjusted for season and ethnicity).
Model 2 is adjusted for ethnicity, head of household social class, mothers and partners education, time spent outdoors during summer (age 8.5 years), UVB protection
score, WISC IQ score at 8.5 years, BMI, family history of psychiatric problems and puberty stage.
Model 3 is adjusted for Model 2 plus serum concentrations of other hormones/metabolites which are related to vitamin D homoeostasis (eg. association of 25(OH)D3 is
adjusted for 25(OH)D2, phosphate, albumin-adjusted calcium and parathyroid hormone).
aThe numbers included are the same for each model but differ by outcome: total difficulties n = 2413, emotional symptoms n= 2559, conduct problems n = 2502,
hyperactivity n = 2570, peer problems n = 2447 and pro-social problems n= 2666.
doi:10.1371/journal.pone.0040097.t003
Table 4. Association of 25(OH)D3 and 25(OH)D2 concentrations with incident behavioural problems assessed by Strengths and
Difficulties Questionnaire at mean age 11.7 years in children with exposures assessed at 7- or 9-year clinic (mean age 9.4 years,
N = 2072–2267a).
Exposure Outcomea
Odds ratio for category change per
doubling of exposure (95%CI)
Model 1 Model 2 Model 3
25(OH)D3 Total difficulties 0.87 (0.74, 1.01) 0.87 (0.74, 1.01) 0.87 (0.73, 1.01)
Emotional symptoms 0.96 (0.85, 1.06) 0.96 (0.86, 1.06) 0.96 (0.85, 1.07)
Conduct problems 0.93 (0.83, 1.05) 0.93 (0.82, 1.05) 0.93 (0.82, 1.05)
Hyperactivity 1.05 (0.93, 1.19) 1.05 (0.93, 1.19) 1.04 (0.90, 1.19)
Peer relationship problems 0.95 (0.84, 1.05) 0.97 (0.86, 1.07) 0.96 (0.85, 1.08)
Pro-social problems 0.84 (0.72, 0.97) 0.83 (0.70, 0.97) 0.83 (0.71, 0.97)
25(OH)D2 Total difficulties 0.90 (0.71, 1.14) 0.89 (0.69, 1.12) 0.87 (0.68, 1.10)
Emotional symptoms 1.06 (0.87, 1.31) 1.06 (0.85, 1.31) 1.05 (0.84, 1.30)
Conduct problems 1.02 (0.87, 1.20) 1.01 (0.85, 1.19) 1.00 (0.83, 1.18)
Hyperactivity 1.12 (0.91, 1.35) 1.10 (0.88, 1.36) 1.10 (0.87, 1.37)
Peer relationship problems 1.08 (0.90, 1.27) 1.07 (0.90, 1.26) 1.07 (0.90, 1.28)
Pro-social problems 1.19 (0.90, 1.56) 1.22 (0.91, 1.63) 1.17 (0.87, 1.54)
Model 1 is unadjusted (the exposures are standardised for age and gender and 25(OH)D3 is adjusted for season and ethnicity).
Model 2 is adjusted for ethnicity, head of household social class, mothers and partners education, time spent outdoors during summer (age 8.5 years), UVB protection
score, WISC IQ score at 8.5 years, BMI, family history of psychiatric problems and puberty stage.
Model 3 is adjusted for Model 2 plus serum concentrations of other hormones/metabolites which are related to vitamin D homoeostasis (eg. association of 25(OH)D3 is
adjusted for 25(OH)D2, phosphate, albumin-adjusted calcium and parathyroid hormone).
anumbers included are the same for each model but differ by outcome total difficulties n = 2072, emotional symptoms n= 2186, conduct problems n = 2139,
hyperactivity n = 2197, peer problems n = 2097 and pro-social problems n= 2267.
doi:10.1371/journal.pone.0040097.t004
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[20,21]. Thus, vitamin D status during pregnancy or childhood
does not seem to be related to behavioural problems in children.
Limitation of our study is small number of children who were
classified as having behavioural problems on the basis of
established cut-off values. However, the distribution of scores in
each SDQ scale was similar to normative data from British 11–15
year-old children [31] and analysing the association with actual
scores led to similar conclusions. Our sample was also considerably
larger than in the previous studies assessing the association
between vitamin D status in pregnancy and childhood behaviours
(n = 177 in [21] and n= 743 in [20]).Other strengths of our study
include prospective assessment of behavioural problems, exclusion
children with previous behavioural problems to avoid reverse
causality and the ability to examine potential confounding by a
wide range of characteristics. We were also able to study the
associations of 25(OH)D3 and 25(OH)D2 separately. The children
who were lost to follow-up tended to be from lower socioeconomic
background [25], but the distributions of SDQ scores were similar
among those included and those who were excluded because of
missing data on confounders or exposures. By including blood
samples taken at the three clinics we minimised exclusion because
of non-attendance at one of the follow-up clinics. The distribution
of 25(OH)D concentrations was similar to other studies on
Northern hemisphere [32,33], so our results are likely to be
generalisable to most Northern hemisphere populations with
similar vitamin D concentrations, but may not generalise to those
with very different dietary intakes or UVB exposure.
Although better vitamin D status, indicated by 25(OH)D
concentrations has been associated with better cognitive function
and mental health [2–4,6–12,34], higher serum concentrations of
25(OH)D3 and 25(OH)D2 were not associated with lower risk of
behavioural problems. Thus, vitamin D status is unlikely to be a
determinant of behavioural problems in children.
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